The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Blood–brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis
Abstract
Enhanced cerebrovascular permeability and cellular infiltration mark the onset of early multiple sclerosis lesions. So far, the precise sequence of these events and their role in lesion formation and disease progression remain unknown. Here we provide quantitative evidence that blood-brain barrier leakage is an early event and precedes massive cellular infiltration in the development of acute experimental allergic encephalomyelitis (EAE), the animal correlate of multiple sclerosis. Cerebrovascular leakage and monocytes infiltrates were separately monitored by quantitative in vivo MRI during the course of the disease. Magnetic resonance enhancement of the contrast agent gadolinium diethylenetriaminepentaacetate (Gd-DTPA), reflecting vascular leakage, occurred concomitantly with the onset of neurological signs and was already at a maximal level at this stage of the disease. Immunohistochemical analysis also confirmed the presence of the serum-derived proteins such as fibrinogen around the brain vessels early in the disease, whereas no cellular infiltrates could be detected. MRI further demonstrated that Gd-DTPA leakage clearly preceded monocyte infiltration as imaged by the contrast agent based on ultra small particles of iron oxide (USPIO), which was maximal only during full-blown EAE. Ultrastructural and immunohistochemical investigation revealed that USPIOs were present in newly infiltrated macrophages within the inflammatory lesions. To validate the use of USPIOs as a non-invasive tool to evaluate therapeutic strategies, EAE animals were treated with the immunomodulator 3-hydroxy-3-methylglutaryl Coenzyme A reductase inhibitor, lovastatin, which ameliorated clinical scores. MRI showed that the USPIO load in the brain was significantly diminished in lovastatin-treated animals. Data indicate that cerebrovascular leakage and monocytic trafficking into the brain are two distinct processes in the development of inflammatory lesions during multiple sclerosis, which can be monitored on-line with MRI using USPIOs and Gd-DTPA as contrast agents. These studies also implicate that USPIOs are a valuable tool to visualize monocyte infiltration in vivo and quantitatively assess the efficacy of new therapeutics like lovastatin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin
Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., & Karin, N. (1992) · Nature · doi:10.1038/356063a0 · Cited by 1,737
Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging
Tofts, P. S. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070113 · Cited by 1,478
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Miller, D. H., Khan, O. A., Sheremata, W. A., Blumhardt, L. D., Rice, G. P. A., Libonati, M. A., Willmer-Hulme, A. J., Dalton, C. M., Miszkiel, K. A., & O'Connor, P. W. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020696 · Cited by 1,242
Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097
Baron, J. L., Madri, J. A., Ruddle, N. H., Hashim, G., & Janeway, C. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.57 · Cited by 835
Histochemical Comparison of Naphthol AS-Phosphates for the Demonstration of Phosphatases
(1958) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/20.3.601 · Cited by 531
Brück, W., Bitsch, A., Kolenda, H., Brück, Y., Stiefel, M., & Lassmann, H. (1997) · Annals of Neurology · doi:10.1002/ana.410420515 · Cited by 519
Cited by
The Blood-Brain Barrier in Brain Homeostasis and Neurological Diseases
Weiss, N., Miller, F., Cazaubon, S., & Couraud, P.-O. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.022 · Cited by 731
Cellular mechanisms of IL-17-induced blood-brain barrier disruption
Huppert, J., Closhen, D., Croxford, A., White, R., Kulig, P., Pietrowski, E., Bechmann, I., Becher, B., Luhmann, H. J., Waisman, A., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-141978 · Cited by 529
Inflammation and Atherosclerosis: Novel Insights Into Plaque Formation and Destabilization
Stoll, G., & Bendszus, M. (2006) · Stroke · doi:10.1161/01.str.0000226901.34927.10 · Cited by 503
Weinstein, J. S., Varallyay, C. G., Dosa, E., Gahramanov, S., Hamilton, B., Rooney, W. D., Muldoon, L. L., & Neuwelt, E. A. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.192 · Cited by 500
Nanoparticles for Brain Drug Delivery
Masserini, M. (2013) · ISRN Biochemistry · doi:10.1155/2013/238428 · Cited by 489
Mikita, J., Dubourdieu-Cassagno, N., Deloire, M. S., Vekris, A., Biran, M., Raffard, G., Brochet, B., Canron, M.-H., Franconi, J.-M., Boiziau, C., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458510379243 · Cited by 358
Research review on the pharmacological effects of astragaloside IV
Li, L., Hou, X., Xu, R., Liu, C., & Tu, M. (2017) · Fundamental & Clinical Pharmacology · doi:10.1111/fcp.12232 · Cited by 330
Hendrickx, D. A. E., van Eden, C. G., Schuurman, K. G., Hamann, J., & Huitinga, I. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.04.007 · Cited by 313
Cheng, K. K., Chan, P. S., Fan, S., Kwan, S. M., Yeung, K. L., Wáng, Y.-X. J., Chow, A. H. L., Wu, E. X., & Baum, L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.005 · Cited by 293
Innate Immunity in the CNS: Redefining the Relationship between the CNS and Its Environment
Lampron, A., ElAli, A., & Rivest, S. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.005 · Cited by 284
Statins: Mechanisms of neuroprotection
van der Most, P. J., Dolga, A. M., Nijholt, I. M., Luiten, P. G. M., & Eisel, U. L. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.02.002 · Cited by 268
“In addition, animal models suggest that statins may be beneficial in the treatment of multiple sclerosis (MS) (Aktas et al., 2003; Floris et al., 2004; Greenwood et al., 2003; Paintlia et al., 2004) and during acute stroke (Berger et al., 2008; Chen et al., 2005; Sironi et al., 2003).”
Perivascular microglia promote blood vessel disintegration in the ischemic penumbra
Jolivel, V., Bicker, F., Binamé, F., Ploen, R., Keller, S., Gollan, R., Jurek, B., Birkenstock, J., Poisa-Beiro, L., Bruttger, J., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1372-1 · Cited by 265
How Do Immune Cells Support and Shape the Brain in Health, Disease, and Aging?
Schwartz, M., Kipnis, J., Rivest, S., & Prat, A. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3241-13.2013 · Cited by 259
Stolp, H. B., & Dziegielewska, K. M. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.01005.x · Cited by 257
Vellinga, M. M., Oude Engberink, R. D., Seewann, A., Pouwels, P. J. W., Wattjes, M. P., van der Pol, S. M. A., Pering, C., Polman, C. H., de Vries, H. E., Geurts, J. J. G., et al. (2008) · Brain · doi:10.1093/brain/awn009 · Cited by 183
“The clinical relevance of this distinction is emphasized by data showing that USPIO-enhancement correlated with disability, axonal loss and response to therapy (Floris et al., 2004; Rausch et al., 2004; Brochet et al., 2006).”
BackgroundInfluentialEndothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis
Lengfeld, J. E., Lutz, S. E., Smith, J. R., Diaconu, C., Scott, C., Kofman, S. B., Choi, C., Walsh, C. M., Raine, C. S., Agalliu, I., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609905114 · Cited by 152
Morgan, L., Shah, B., Rivers, L. E., Barden, L., Groom, A. J., Chung, R., Higazi, D., Desmond, H., Smith, T., & Staddon, J. M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.04.051 · Cited by 118
Protection of Fecal Microbiota Transplantation in a Mouse Model of Multiple Sclerosis
Li, K., Wei, S., Hu, L., Yin, X., Mai, Y., Jiang, C., Peng, X., Cao, X., Huang, Z., Zhou, H., et al. (2020) · Mediators of Inflammation · doi:10.1155/2020/2058272 · Cited by 92
Cain, M. D., Salimi, H., Gong, Y., Yang, L., Hamilton, S. L., Heffernan, J. R., Hou, J., Miller, M. J., & Klein, R. S. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.04.008 · Cited by 86
Tourdias, T., Roggerone, S., Filippi, M., Kanagaki, M., Rovaris, M., Miller, D. H., Petry, K. G., Brochet, B., Pruvo, J.-P., Radüe, E.-W., et al. (2012) · Radiology · doi:10.1148/radiol.12111416 · Cited by 85
Andjus, P. R., Bataveljić, D., Vanhoutte, G., Mitrecic, D., Pizzolante, F., Djogo, N., Nicaise, C., Kengne, F. G., Gangitano, C., Michetti, F., et al. (2009) · The Anatomical Record · doi:10.1002/ar.20995 · Cited by 65
Macrophage diversity in cardiac inflammation: A review
Barin, J. G., Rose, N. R., & Čiháková, D. (2012) · Immunobiology · doi:10.1016/j.imbio.2011.06.009 · Cited by 56
Paintlia, A. S., Paintlia, M. K., Singh, A. K., & Singh, I. (2013) · Glia · doi:10.1002/glia.22537 · Cited by 43
“Statinmediated inhibition of small Rho GTPases activity reduces inflammatory components (myelin reactive CD41 Th1 and Th17 cells), endothelial dysfunction, and CNS inflammation in the EAE model (Dunn et al., 2006; Floris et al., 2004; Greenwood et al., 2003).”
BackgroundMRI of optic neuritis in a rat model
Boretius, S., Gadjanski, I., Demmer, I., Bähr, M., Diem, R., Michaelis, T., & Frahm, J. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.02.021 · Cited by 37
“Despite a vast amount of MRI literature of EAE animal models (Berger et al., 2006; Blezer et al., 2007; Boretius et al., 2006; Floris et al., 2004; Nessler et al., 2007), only few studies have focused on ON (Guy et al.”
BackgroundMRI confirms loss of blood–brain barrier integrity in a mouse model of disseminated candidiasis
Navarathna, D. H. M. L. P., Munasinghe, J., Lizak, M. J., Nayak, D., McGavern, D. B., & Roberts, D. D. (2013) · NMR in Biomedicine · doi:10.1002/nbm.2926 · Cited by 34
Guglielmetti, C., Levi, J., Huynh, T. L., Tiret, B., Blecha, J., Tang, R., VanBrocklin, H., & Chaumeil, M. M. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.259325 · Cited by 28
“T1 contrast-enhanced MRI indicated BBB alterations following EAE immunization, as previously described (29), and detected Fingolimod efficacy as no BBB disruption was observed in treated animals, supporting Fingolimod’s action on endothelial cells (30).”
BackgroundMaarouf, A., Ferré, J.-C., Zaaraoui, W., Le Troter, A., Bannier, E., Berry, I., Guye, M., Pierot, L., Barillot, C., Pelletier, J., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515607649 · Cited by 22
Liao, K., Niu, F., Hu, G., & Buch, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.984375 · Cited by 16
Vigne, S., Duc, D., Peter, B., Rebeaud, J., Yersin, Y., Ruiz, F., Bressoud, V., Collet, T.-H., & Pot, C. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02409-x · Cited by 16
Zivadinov, R., Schweser, F., Dwyer, M. G., & Pol, S. (2020) · Journal of Neuroimaging · doi:10.1111/jon.12768 · Cited by 9
Metadata
- Authors
- Floris, S., Blezer, E. L. A., Schreibelt, G., Döpp, E., van der Pol, S. M. A., Schadee‐Eestermans, I. L., Nicolay, K., Dijkstra, C. D., & de Vries, H. E.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-03
- Volume
- 127
- Issue
- 3
- Pages
- 616-627
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2164268814
- Cited by
- 272
- References
- 62
- FWCI
- 11.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.